{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:51:18Z","timestamp":1792144278392,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10571-019-00751-y","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T05:03:53Z","timestamp":1573016633000},"page":"531-546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases"],"prefix":"10.1007","volume":"40","author":[{"given":"Cristina","family":"Barbagallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Mostile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloriangela","family":"Baglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Raciti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Zappia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Purrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4282-920X","authenticated-orcid":false,"given":"Marco","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"issue":"12","key":"751_CR1","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"JD Arroyo","year":"2011","unstructured":"Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108(12):5003\u20135008. \nhttps:\/\/doi.org\/10.1073\/pnas.1019055108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"751_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.euroneuro.2013.03.007","volume":"25","author":"TA Bayer","year":"2015","unstructured":"Bayer TA (2015) Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders? Eur Neuropsychopharmacol 25(5):713\u2013724. \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2013.03.007","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1\u20133","key":"751_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1385\/MN:24:1-3:087","volume":"24","author":"K Blennow","year":"2001","unstructured":"Blennow K, Vanmechelen E, Hampel H (2001) CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer\u2019s disease. Mol Neurobiol 24(1\u20133):87\u201397. \nhttps:\/\/doi.org\/10.1385\/MN:24:1-3:087","journal-title":"Mol Neurobiol"},{"issue":"8","key":"751_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jnr.23377","volume":"92","author":"T Botta-Orfila","year":"2014","unstructured":"Botta-Orfila T, Morato X, Compta Y, Lozano JJ, Falgas N, Valldeoriola F, Pont-Sunyer C, Vilas D, Mengual L, Fernandez M, Molinuevo JL, Antonell A, Marti MJ, Fernandez-Santiago R, Ezquerra M (2014) Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson\u2019s disease. J Neurosci Res 92(8):1071\u20131077. \nhttps:\/\/doi.org\/10.1002\/jnr.23377","journal-title":"J Neurosci Res"},{"key":"751_CR5","doi-asserted-by":"publisher","first-page":"b158","DOI":"10.1136\/bmj.b158","volume":"338","author":"A Burns","year":"2009","unstructured":"Burns A, Iliffe S (2009) Alzheimer\u2019s disease. BMJ 338:b158. \nhttps:\/\/doi.org\/10.1136\/bmj.b158","journal-title":"BMJ"},{"issue":"1","key":"751_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/14737159.2018.1412258","volume":"18","author":"SA Byrnes","year":"2018","unstructured":"Byrnes SA, Weigl BH (2018) Selecting analytical biomarkers for diagnostic applications: a first principles approach. Expert Rev Mol Diagn 18(1):19\u201326. \nhttps:\/\/doi.org\/10.1080\/14737159.2018.1412258","journal-title":"Expert Rev Mol Diagn"},{"key":"751_CR7","doi-asserted-by":"publisher","first-page":"7027380","DOI":"10.1155\/2017\/7027380","volume":"2017","author":"JJ Chen","year":"2017","unstructured":"Chen JJ, Zhao B, Zhao J, Li S (2017) Potential roles of exosomal microRNAs as diagnostic biomarkers and therapeutic application in Alzheimer\u2019s disease. Neural Plast 2017:7027380. \nhttps:\/\/doi.org\/10.1155\/2017\/7027380","journal-title":"Neural Plast"},{"key":"751_CR8","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.23743","author":"L Cheng","year":"2014","unstructured":"Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles. \nhttps:\/\/doi.org\/10.3402\/jev.v3.23743","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"751_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-0404.2011.01583.x","volume":"126","author":"D Contrafatto","year":"2012","unstructured":"Contrafatto D, Mostile G, Nicoletti A, Dibilio V, Raciti L, Lanzafame S, Luca A, Distefano A, Zappia M (2012) [(123) I]FP-CIT-SPECT asymmetry index to differentiate Parkinson\u2019s disease from vascular Parkinsonism. Acta Neurol Scand 126(1):12\u201316. \nhttps:\/\/doi.org\/10.1111\/j.1600-0404.2011.01583.x","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"751_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","volume":"8","author":"MA Cortez","year":"2011","unstructured":"Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA (2011) MicroRNAs in body fluids\u2013the mix of hormones and biomarkers. Nat Rev Clin Oncol 8(8):467\u2013477. \nhttps:\/\/doi.org\/10.1038\/nrclinonc.2011.76","journal-title":"Nat Rev Clin Oncol"},{"issue":"10\u201311","key":"751_CR11","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.clinbiochem.2013.03.015","volume":"46","author":"V De Guire","year":"2013","unstructured":"De Guire V, Robitaille R, Tetreault N, Guerin R, Menard C, Bambace N, Sapieha P (2013) Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clin Biochem 46(10\u201311):846\u2013860. \nhttps:\/\/doi.org\/10.1016\/j.clinbiochem.2013.03.015","journal-title":"Clin Biochem"},{"issue":"1","key":"751_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/neu.2013.3040","volume":"31","author":"R Diaz-Arrastia","year":"2014","unstructured":"Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, McMahon PJ, Inoue T, Yuh EL, Lingsma HF, Maas AI, Valadka AB, Okonkwo DO, Manley GT, Investigators T-T (2014) Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma 31(1):19\u201325. \nhttps:\/\/doi.org\/10.1089\/neu.2013.3040","journal-title":"J Neurotrauma"},{"issue":"2","key":"751_CR13","first-page":"93","volume":"83","author":"CM Doherty","year":"2014","unstructured":"Doherty CM, Forbes RB (2014) Diagnostic lumbar puncture. Ulster Med J 83(2):93\u2013102","journal-title":"Ulster Med J"},{"issue":"46","key":"751_CR14","doi-asserted-by":"publisher","first-page":"75353","DOI":"10.18632\/oncotarget.12205","volume":"7","author":"A ElSharawy","year":"2016","unstructured":"ElSharawy A, Roder C, Becker T, Habermann JK, Schreiber S, Rosenstiel P, Kalthoff H (2016) Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations. Oncotarget 7(46):75353\u201375365. \nhttps:\/\/doi.org\/10.18632\/oncotarget.12205","journal-title":"Oncotarget"},{"key":"751_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-4939-7601-0_6","volume":"1733","author":"GR Fries","year":"2018","unstructured":"Fries GR, Quevedo J (2018) Exosomal microRNAs as potential biomarkers in neuropsychiatric disorders. Methods Mol Biol 1733:79\u201385. \nhttps:\/\/doi.org\/10.1007\/978-1-4939-7601-0_6","journal-title":"Methods Mol Biol"},{"issue":"4","key":"751_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3233\/JAD-140756","volume":"42","author":"D Galimberti","year":"2014","unstructured":"Galimberti D, Villa C, Fenoglio C, Serpente M, Ghezzi L, Cioffi SM, Arighi A, Fumagalli G, Scarpini E (2014) Circulating miRNAs as potential biomarkers in Alzheimer\u2019s disease. J Alzheimers Dis 42(4):1261\u20131267. \nhttps:\/\/doi.org\/10.3233\/JAD-140756","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"751_CR17","doi-asserted-by":"publisher","first-page":"e30679","DOI":"10.1371\/journal.pone.0030679","volume":"7","author":"A Gallo","year":"2012","unstructured":"Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 7(3):e30679. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0030679","journal-title":"PLoS ONE"},{"issue":"2","key":"751_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.expneurol.2011.11.026","volume":"235","author":"H Geekiyanage","year":"2012","unstructured":"Geekiyanage H, Jicha GA, Nelson PT, Chan C (2012) Blood serum miRNA: non-invasive biomarkers for Alzheimer\u2019s disease. Exp Neurol 235(2):491\u2013496. \nhttps:\/\/doi.org\/10.1016\/j.expneurol.2011.11.026","journal-title":"Exp Neurol"},{"issue":"4","key":"751_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","volume":"80","author":"C Iadecola","year":"2013","unstructured":"Iadecola C (2013) The pathobiology of vascular dementia. Neuron 80(4):844\u2013866. \nhttps:\/\/doi.org\/10.1016\/j.neuron.2013.10.008","journal-title":"Neuron"},{"issue":"4","key":"751_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Contributors (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14(4):535\u2013562. \nhttps:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"issue":"4","key":"751_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatr 79(4):368\u2013376. \nhttps:\/\/doi.org\/10.1136\/jnnp.2007.131045","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"2","key":"751_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2217\/14750708.5.2.237","volume":"5","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) Vascular Parkinsonism. Therapy 5(2):237\u2013255. \nhttps:\/\/doi.org\/10.2217\/14750708.5.2.237","journal-title":"Therapy"},{"issue":"3","key":"751_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1212\/WNL.51.3.728","volume":"51","author":"AF Jorm","year":"1998","unstructured":"Jorm AF, Jolley D (1998) The incidence of dementia: a meta-analysis. Neurology 51(3):728\u2013733","journal-title":"Neurology"},{"issue":"4","key":"751_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3233\/JPD-012144","volume":"2","author":"SK Khoo","year":"2012","unstructured":"Khoo SK, Petillo D, Kang UJ, Resau JH, Berryhill B, Linder J, Forsgren L, Neuman LA, Tan AC (2012) Plasma-based circulating MicroRNA biomarkers for Parkinson\u2019s disease. J Parkinsons Dis 2(4):321\u2013331. \nhttps:\/\/doi.org\/10.3233\/JPD-012144","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"751_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrneurol.2015.61","volume":"11","author":"AD Korczyn","year":"2015","unstructured":"Korczyn AD (2015) Vascular Parkinsonism\u2013characteristics, pathogenesis and treatment. Nat Rev Neurol 11(6):319\u2013326. \nhttps:\/\/doi.org\/10.1038\/nrneurol.2015.61","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"751_CR26","doi-asserted-by":"publisher","first-page":"e69807","DOI":"10.1371\/journal.pone.0069807","volume":"8","author":"P Kumar","year":"2013","unstructured":"Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, Bernier F, Yanagimachi M, Aoshima K, Oda Y (2013) Circulating miRNA biomarkers for Alzheimer\u2019s disease. PLoS ONE 8(7):e69807. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0069807","journal-title":"PLoS ONE"},{"key":"751_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0072-9752(07)01219-5","volume":"89","author":"OL Lopez","year":"2008","unstructured":"Lopez OL, Dekosky ST (2008) Clinical symptoms in Alzheimer\u2019s disease. Handb Clin Neurol 89:207\u2013216. \nhttps:\/\/doi.org\/10.1016\/S0072-9752(07)01219-5","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"751_CR28","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1038\/s41598-018-26525-y","volume":"8","author":"AY Mandourah","year":"2018","unstructured":"Mandourah AY, Ranganath L, Barraclough R, Vinjamuri S, Hof RV, Hamill S, Czanner G, Dera AA, Wang D, Barraclough DL (2018) Circulating microRNAs as potential diagnostic biomarkers for osteoporosis. Sci Rep 8(1):8421. \nhttps:\/\/doi.org\/10.1038\/s41598-018-26525-y","journal-title":"Sci Rep"},{"issue":"3","key":"751_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jbiotec.2011.01.023","volume":"152","author":"R Margis","year":"2011","unstructured":"Margis R, Margis R, Rieder CR (2011) Identification of blood microRNAs associated to Parkinsonis disease. J Biotechnol 152(3):96\u2013101. \nhttps:\/\/doi.org\/10.1016\/j.jbiotec.2011.01.023","journal-title":"J Biotechnol"},{"key":"751_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fneur.2018.00156","volume":"9","author":"L Marsili","year":"2018","unstructured":"Marsili L, Rizzo G, Colosimo C (2018) Diagnostic criteria for Parkinson\u2019s disease: from James Parkinson to the concept of prodromal disease. Front Neurol 9:156. \nhttps:\/\/doi.org\/10.3389\/fneur.2018.00156","journal-title":"Front Neurol"},{"issue":"6","key":"751_CR31","doi-asserted-by":"publisher","first-page":"a008870","DOI":"10.1101\/cshperspect.a008870","volume":"2","author":"J Massano","year":"2012","unstructured":"Massano J, Bhatia KP (2012) Clinical approach to Parkinson\u2019s disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2(6):a008870. \nhttps:\/\/doi.org\/10.1101\/cshperspect.a008870","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"30","key":"751_CR32","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O\u2019Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513\u201310518. \nhttps:\/\/doi.org\/10.1073\/pnas.0804549105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"751_CR33","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10072-016-2489-x","volume":"37","author":"G Mostile","year":"2016","unstructured":"Mostile G, Nicoletti A, Cicero CE, Cavallaro T, Bruno E, Dibilio V, Luca A, Sciacca G, Raciti L, Contrafatto D, Chiaramonte I, Zappia M (2016) Magnetic resonance Parkinsonism index in progressive supranuclear palsy and vascular Parkinsonism. Neurol Sci 37(4):591\u2013595. \nhttps:\/\/doi.org\/10.1007\/s10072-016-2489-x","journal-title":"Neurol Sci"},{"key":"751_CR34","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fneur.2018.00411","volume":"9","author":"G Mostile","year":"2018","unstructured":"Mostile G, Nicoletti A, Zappia M (2018) Vascular Parkinsonism: still looking for a diagnosis. Front Neurol 9:411. \nhttps:\/\/doi.org\/10.3389\/fneur.2018.00411","journal-title":"Front Neurol"},{"issue":"3","key":"751_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/1573406411666151030112140","volume":"12","author":"G Mushtaq","year":"2016","unstructured":"Mushtaq G, Greig NH, Anwar F, Zamzami MA, Choudhry H, Shaik MM, Tamargo IA, Kamal MA (2016) miRNAs as circulating biomarkers for Alzheimer\u2019s disease and Parkinson\u2019s disease. Med Chem 12(3):217\u2013225","journal-title":"Med Chem"},{"issue":"8","key":"751_CR36","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","volume":"13","author":"S Norton","year":"2014","unstructured":"Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C (2014) Potential for primary prevention of Alzheimer\u2019s disease: an analysis of population-based data. Lancet Neurol 13(8):788\u2013794. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(14)70136-X","journal-title":"Lancet Neurol"},{"issue":"10004","key":"751_CR37","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","volume":"386","author":"JT O\u2019Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A (2015) Vascular dementia. Lancet 386(10004):1698\u20131706. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(15)00463-8","journal-title":"Lancet"},{"issue":"1","key":"751_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mds.25373","volume":"28","author":"CW Olanow","year":"2013","unstructured":"Olanow CW, Brundin P (2013) Parkinson\u2019s disease and alpha synuclein: is Parkinson\u2019s disease a prion-like disorder? Mov Disord 28(1):31\u201340. \nhttps:\/\/doi.org\/10.1002\/mds.25373","journal-title":"Mov Disord"},{"issue":"2","key":"751_CR39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","volume":"11","author":"C Qiu","year":"2009","unstructured":"Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11(2):111\u2013128","journal-title":"Dialogues Clin Neurosci"},{"key":"751_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fncel.2016.00051","volume":"10","author":"M Ragusa","year":"2016","unstructured":"Ragusa M, Bosco P, Tamburello L, Barbagallo C, Condorelli AG, Tornitore M, Spada RS, Barbagallo D, Scalia M, Elia M, Di Pietro C, Purrello M (2016) miRNAs plasma profiles in vascular dementia: biomolecular data and biomedical implications. Front Cell Neurosci 10:51. \nhttps:\/\/doi.org\/10.3389\/fncel.2016.00051","journal-title":"Front Cell Neurosci"},{"key":"751_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fmolb.2017.00066","volume":"4","author":"M Ragusa","year":"2017","unstructured":"Ragusa M, Barbagallo C, Cirnigliaro M, Battaglia R, Brex D, Caponnetto A, Barbagallo D, Di Pietro C, Purrello M (2017) Asymmetric RNA distribution among cells and their secreted exosomes: biomedical meaning and considerations on diagnostic applications. Front Mol Biosci 4:66. \nhttps:\/\/doi.org\/10.3389\/fmolb.2017.00066","journal-title":"Front Mol Biosci"},{"issue":"3","key":"751_CR42","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1586\/14737159.2015.1002469","volume":"15","author":"C Reitz","year":"2015","unstructured":"Reitz C (2015) Genetic diagnosis and prognosis of Alzheimer\u2019s disease: challenges and opportunities. Expert Rev Mol Diagn 15(3):339\u2013348. \nhttps:\/\/doi.org\/10.1586\/14737159.2015.1002469","journal-title":"Expert Rev Mol Diagn"},{"key":"751_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13041-015-0133-y","volume":"8","author":"R Rizzo","year":"2015","unstructured":"Rizzo R, Ragusa M, Barbagallo C, Sammito M, Gulisano M, Cali PV, Pappalardo C, Barchitta M, Granata M, Condorelli AG, Barbagallo D, Scalia M, Agodi A, Di Pietro C, Purrello M (2015) Circulating miRNAs profiles in tourette syndrome: molecular data and clinical implications. Mol Brain 8:44. \nhttps:\/\/doi.org\/10.1186\/s13041-015-0133-y","journal-title":"Mol Brain"},{"issue":"2","key":"751_CR44","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Roman","year":"1993","unstructured":"Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43(2):250\u2013260","journal-title":"Neurology"},{"issue":"3","key":"751_CR45","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/WAD.0000000000000034","volume":"28","author":"P Sachdev","year":"2014","unstructured":"Sachdev P, Kalaria R, O\u2019Brien J, Skoog I, Alladi S, Black SE, Blacker D, Blazer DG, Chen C, Chui H, Ganguli M, Jellinger K, Jeste DV, Pasquier F, Paulsen J, Prins N, Rockwood K, Roman G, Scheltens P, Internationlal Society for Vascular B, Cognitive D (2014) Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord 28(3):206\u2013218. \nhttps:\/\/doi.org\/10.1097\/WAD.0000000000000034","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"751_CR46","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1192\/apt.bp.110.008888","volume":"18","author":"H Series","year":"2012","unstructured":"Series H, Esiri M (2012) Vascular dementia: a pragmatic review. Adv Psychiatr Treat 18(5):372\u2013380. \nhttps:\/\/doi.org\/10.1192\/apt.bp.110.008888","journal-title":"Adv Psychiatr Treat"},{"issue":"1","key":"751_CR47","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189. \nhttps:\/\/doi.org\/10.1101\/cshperspect.a006189","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"751_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13195-017-0316-0","volume":"9","author":"KS Sheinerman","year":"2017","unstructured":"Sheinerman KS, Toledo JB, Tsivinsky VG, Irwin D, Grossman M, Weintraub D, Hurtig HI, Chen-Plotkin A, Wolk DA, McCluskey LF, Elman LB, Trojanowski JQ, Umansky SR (2017) Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimers Res Ther 9(1):89. \nhttps:\/\/doi.org\/10.1186\/s13195-017-0316-0","journal-title":"Alzheimers Res Ther"},{"key":"751_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.pathol.1.110304.100113","volume":"1","author":"DM Skovronsky","year":"2006","unstructured":"Skovronsky DM, Lee VM, Trojanowski JQ (2006) Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol 1:151\u2013170. \nhttps:\/\/doi.org\/10.1146\/annurev.pathol.1.110304.100113","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"751_CR50","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1042\/CS20160607","volume":"131","author":"EE Smith","year":"2017","unstructured":"Smith EE (2017) Clinical presentations and epidemiology of vascular dementia. Clin Sci (Lond) 131(11):1059\u20131068. \nhttps:\/\/doi.org\/10.1042\/CS20160607","journal-title":"Clin Sci (Lond)"},{"issue":"1\u20132","key":"751_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2013.10.002","volume":"336","author":"L Tan","year":"2014","unstructured":"Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N, Wang YL, Sun L, Jiang T, Tan L (2014) Circulating miR-125b as a biomarker of Alzheimer\u2019s disease. J Neurol Sci 336(1\u20132):52\u201356. \nhttps:\/\/doi.org\/10.1016\/j.jns.2013.10.002","journal-title":"J Neurol Sci"},{"key":"751_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3410\/b3-15","volume":"3","author":"C Thery","year":"2011","unstructured":"Thery C (2011) Exosomes: secreted vesicles and intercellular communications. Biol Rep 3:15. \nhttps:\/\/doi.org\/10.3410\/b3-15","journal-title":"Biol Rep"},{"issue":"9","key":"751_CR53","doi-asserted-by":"publisher","first-page":"H1085","DOI":"10.1152\/ajpheart.00191.2012","volume":"303","author":"AJ Tijsen","year":"2012","unstructured":"Tijsen AJ, Pinto YM, Creemers EE (2012) Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol 303(9):H1085\u2013H1095. \nhttps:\/\/doi.org\/10.1152\/ajpheart.00191.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"16","key":"751_CR54","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","volume":"39","author":"A Turchinovich","year":"2011","unstructured":"Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39(16):7223\u20137233. \nhttps:\/\/doi.org\/10.1093\/nar\/gkr254","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"751_CR55","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654\u2013659. \nhttps:\/\/doi.org\/10.1038\/ncb1596","journal-title":"Nat Cell Biol"},{"key":"751_CR56","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fncel.2014.00156","volume":"8","author":"A Vallelunga","year":"2014","unstructured":"Vallelunga A, Ragusa M, Di Mauro S, Iannitti T, Pilleri M, Biundo R, Weis L, Di Pietro C, De Iuliis A, Nicoletti A, Zappia M, Purrello M, Antonini A (2014) Identification of circulating microRNAs for the differential diagnosis of Parkinson\u2019s disease and Multiple System Atrophy. Front Cell Neurosci 8:156. \nhttps:\/\/doi.org\/10.3389\/fncel.2014.00156","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"751_CR57","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00401-011-0880-5","volume":"122","author":"S Venneti","year":"2011","unstructured":"Venneti S, Robinson JL, Roy S, White MT, Baccon J, Xie SX, Trojanowski JQ (2011) Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases. Acta Neuropathol 122(6):737\u2013745. \nhttps:\/\/doi.org\/10.1007\/s00401-011-0880-5","journal-title":"Acta Neuropathol"},{"issue":"6","key":"751_CR58","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/ejcn.2014.259","volume":"69","author":"M Vikdahl","year":"2015","unstructured":"Vikdahl M, Backman L, Johansson I, Forsgren L, Haglin L (2015) Cardiovascular risk factors and the risk of Parkinson\u2019s disease. Eur J Clin Nutr 69(6):729\u2013733. \nhttps:\/\/doi.org\/10.1038\/ejcn.2014.259","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"751_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcp.25056","volume":"231","author":"J Wang","year":"2016","unstructured":"Wang J, Chen J, Sen S (2016) MicroRNA as biomarkers and diagnostics. J Cell Physiol 231(1):25\u201330. \nhttps:\/\/doi.org\/10.1002\/jcp.25056","journal-title":"J Cell Physiol"},{"issue":"1","key":"751_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","volume":"13","author":"J Zhang","year":"2015","unstructured":"Zhang J, Li S, Li L, Li M, Guo C, Yao J, Mi S (2015) Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinform 13(1):17\u201324. \nhttps:\/\/doi.org\/10.1016\/j.gpb.2015.02.001","journal-title":"Genomics Proteomics Bioinform"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-019-00751-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-019-00751-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-019-00751-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T19:18:55Z","timestamp":1604517535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-019-00751-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1007\/s10571-019-00751-y","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethical committee of the Azienda Ospedaliero-Universitaria Policlinico-Vittorio Emanuele, Catania, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}